NCT05647785View on ClinicalTrials.gov

Long-term Follow-up of RESTORE Study

UnknownOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

June 30, 2023

Conditions
Cancer
Interventions
DEVICE

Long-term follow-up of cerena™

Long term follow-up for eligible participants from the RESTORE study

DEVICE

Long-term follow-up of attune™

Long term follow-up for eligible participants from the RESTORE study

Trial Locations (1)

94104

Blue Note Therapeutics, San Francisco

Sponsors
All Listed Sponsors
lead

Blue Note Therapeutics

INDUSTRY

NCT05647785 - Long-term Follow-up of RESTORE Study | Biotech Hunter | Biotech Hunter